4.
C1236T和C3435T不同基因型患者细胞遗传学复发的风险
Risk of cytogenetic relapse in patients with different genotypes of C1236T and C3435T
| SNPs | Genotype | Study group (n=50) | Control group (n=50) | χ2 | P | OR (95% CI) |
| MDR1-C1236T (rs1128503) | ||||||
| CC | 11(78.57%) | 3(21.43%) | 5.316 | 0.021 | 4.419 (1.151, 16.967) | |
| CT+TT | 39 (45.35%) | 47 (54.65%) | ||||
| TT | 7 (33.33%) | 14(66.67%) | 2.954 | 0.086 | 0.419 (0.153, 1.149) | |
| CC+CT | 43 (54.44%) | 36 (45.56%) | ||||
| MDR1-C3435T (rs1045642) | ||||||
| CC | 11(73.33%) | 4(26.67%) | 3.843 | 0.049 | 3.244 (0.956, 11.001) | |
| CT+TT | 39 (45.88%) | 46 (54.12%) | ||||
| TT | 12(31.58%) | 26 (68.42%) | 8.319 | 0.004 | 0.291 (0.124, 0.684) | |
| CC+CT | 38 (61.29%) | 24 (38.71%) | ||||